-
Mashup Score: 96Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial - 10 month(s) ago
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, General HCPsTweet
-
Mashup Score: 6Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 randomized trials - 10 month(s) ago
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, CardiologistsTweet-
@Hragy https://t.co/jo4reP8omH
-
-
Mashup Score: 3Inclisiran in individuals with diabetes or obesity: Post hoc pooled analyses of the ORION‐9, ORION‐10 and ORION‐11 Phase 3 randomized trials - 10 month(s) ago
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, CardiologistsTweet-
@Hragy https://t.co/jo4reP8omH
-
-
Mashup Score: 2Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis - 11 month(s) ago
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, Hem/OncsTweet-
Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta-analysis https://t.co/eBGwo11K0y via @fernandogerchm1 et al https://t.co/8pkseQWw2t
-
-
Mashup Score: 9
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, Expert PicksTweet-
RT @FredRiveraMD: 🔥 Hot off the press 🔥 Sharing our article on the effects of GLP-1RA on blood pressure https://t.co/VfN8RRexY2 Immens…
-
-
Mashup Score: 5
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, Cardiologists1Tweet-
Impact of an online nutrition management application service on glycaemic management in individuals with diabetes: A propensity‐score‐matched retrospective cohort study - Hironaka - Diabetes, Obesity and Metabolism - Wiley Online Library https://t.co/MugxNsHgTX
-
-
Mashup Score: 20
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, CardiologistsTweet-
RT @kamleshkhunti: Our review on Inter-relationship between cardiovascular, renal and metabolic diseases https://t.co/IEOyj2wCfh With Ji…
-
-
Mashup Score: 57
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, General HCPsTweet-
Efficacy and safety of semaglutide 2.4 mg for weight loss in overweight or obese adults without diabetes: An updated systematic review and meta‐analysis including the 2‐year STEP 5 trial - Qin - 2024 - Diabetes, Obesity and Metabolism https://t.co/s0hF6ZldXl
-
-
Mashup Score: 7
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, CardiologistsTweet-
#SGLT2i https://t.co/OAlV1PDQVN
-
-
Mashup Score: 45
Diabetes, Obesity & Metabolism is an interdisciplinary journal for clinical & experimental pharmacology and therapeutics relating to metabolic & endocrine disease.
Categories: General Medicine News, Oncologists2Tweet-
RT @scottisaacsmd: The risk of cardiovascular disease is 89% higher in type 2 diabetes patients with #sarcopenia. https://t.co/dLNfQUBAhg h…
-
Another emerging story in nephrology: Risk prediction is coming of age, especially with a 1A rec in KDIGO 2024 guidelines Great working with @NavTangri to validate the Klinrisk algorithm in the CANVAS & CREDENCE trials Open access: https://t.co/9Nf9GPLxtF More coming soon https://t.co/wmy9DpGQa4